Clinical Trials Logo

Clinical Trial Summary

This study will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic, also in Kampala. While text messages can be used in populations with low literacy, families can opt to receive automated phone call reminders instead. The investigators will pilot assess the impact of vaccine reminders on human papillomavirus (HPV) vaccination. Caregivers of preteens/adolescents will be randomized and stratified by site, language and HPV vaccine dose needed (initiation vs. completion). As this is a feasibility trial, the investigators expect to measure effect size but not necessarily achieve statistical significance.


Clinical Trial Description

Cervical cancer is the leading female cancer in Uganda. Many women are diagnosed with late-stage disease, and 80% of women die within 5 years of diagnosis, making primary prevention critical. HPV is the principal cause of cervical cancer, making vaccination the single most important primary preventive measure. The national HPV vaccination program in Uganda began in November 2015 and focuses solely on preteen/adolescent girls. Two strategies have been adopted for the multi-dose series: 1) school-based and 2) community-based. However, in Kampala, only 29% of girls receive both needed doses. Reasons for undervaccination include school absenteeism on special vaccination days for those receiving vaccination as part of a school program, failing to remember to come to a health facility for a needed dose for those being vaccinated in the community, and lack of knowledge regarding HPV and the vaccines including vaccine misperceptions. While research regarding the use of text message vaccine reminders is strong in the U.S., their use has not yet been demonstrated in a preteen/adolescent population in Sub-Saharan Africa and other low and middle income countries (LMICs). According to the World Bank, currently 89.9% of urban households in Uganda have a cell phone. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05151367
Study type Interventional
Source Columbia University
Contact
Status Completed
Phase N/A
Start date February 23, 2022
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05658198 - Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi
Completed NCT05804825 - Testing the Persuasiveness of Pro-inoculation Arguments N/A
Enrolling by invitation NCT03592225 - Can an Educational Intervention Targeting General Practitioners Increase HPV Vaccination Coverage in AuRA_Lyon (France) N/A
Completed NCT04576962 - County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana
Completed NCT01284374 - Parent-son-provider Decision-making About HPV Vaccination N/A
Recruiting NCT06161831 - HPV Vaccine Reminders - SEARCH II Study N/A